Johnston Janice, Brown Karen, Muir Jeffrey, Sloniewsky Michael J
Arrowhead Health Centers, Glendale, AZ, USA.
KLEO Research, Missoula, MT, USA.
J Pain Res. 2021 Aug 10;14:2413-2421. doi: 10.2147/JPR.S312418. eCollection 2021.
Viscosupplementation (VS) is a safe and effective local treatment for osteoarthritis (OA) of the knee. While much research has been completed evaluating its efficacy, comparatively little research has been completed examining the effects of multiple, repeat courses of treatment versus a single course of treatment.
We retrospectively reviewed real-world data from a large cohort of patients receiving treatment for OA of the knee at 16 rehabilitation clinics. Patients were grouped based on whether they received a single course of treatment or multiple courses. Outcomes for this study included pain (measured via the visual analog scale, VAS) and functional ability (measured via the Western Ontario and McMaster Universities Arthritis Index (WOMAC)). Pain and function scores were collected at baseline (prior to treatment administration) and one week following each course of treatment.
Patients receiving multiple courses of treatment saw greater improvements than those receiving a single course. For VAS, maximal improvement occurred after the fourth course (66% improvement: 1.7±1.2 vs 5.0±2.4 at baseline, p<0.0001). WOMAC scores saw maximal improvement up to the fourth course for all domains (pain: 74%: 2.5±3.3 vs 9.5±5.3, p<0.0001; stiffness: 61%: 1.3±1.0 vs 3.3±2.0, p<0.0001; function: 66%: 9.5±7.2 vs 28.3±14.1, p<0.0001). When scores from multiple courses were averaged, improvements were maintained through the fourth course for VAS (3.4±2.8) and all WOMAC domains (pain: 6.1±5.0; stiffness: 3.0±2.2; function: 23.4±17.3).
Our results indicate that multiple courses of treatment are associated with greater improvements than a single course of VS, and that these improvements continue through four courses of treatment.
关节腔注射透明质酸钠(VS)是治疗膝关节骨关节炎(OA)的一种安全有效的局部治疗方法。虽然已经完成了许多评估其疗效的研究,但相对较少的研究探讨了多次重复疗程治疗与单次疗程治疗的效果差异。
我们回顾性分析了来自16家康复诊所接受膝关节OA治疗的大量患者的真实世界数据。患者根据接受单次疗程治疗还是多次疗程治疗进行分组。本研究的结局指标包括疼痛(通过视觉模拟量表,VAS测量)和功能能力(通过西安大略和麦克马斯特大学骨关节炎指数(WOMAC)测量)。在基线(治疗给药前)和每个疗程治疗后一周收集疼痛和功能评分。
接受多次疗程治疗的患者比接受单次疗程治疗的患者改善更大。对于VAS,最大改善发生在第四个疗程后(改善66%:基线时为5.0±2.4,第四个疗程后为1.7±1.2,p<0.0001)。WOMAC评分在所有领域中,直到第四个疗程都有最大改善(疼痛:74%:基线时为9.5±5.3,第四个疗程后为2.5±3.3,p<0.0001;僵硬:61%:基线时为3.3±2.0,第四个疗程后为1.3±1.0,p<0.0001;功能:66%:基线时为28.3±14.1,第四个疗程后为9.5±7.2,p<0.0001)。当对多个疗程的评分进行平均时,VAS(3.4±2.8)和所有WOMAC领域(疼痛:6.1±5.0;僵硬:3.0±2.2;功能:23.4±17.3)在第四个疗程时仍保持改善。
我们的结果表明,多次疗程治疗比单次VS疗程治疗能带来更大的改善,并且这些改善在四个疗程的治疗中持续存在。